Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Europe    crawled time : 12:30    save search

Ballard announces largest order in company history - 1,000 engines to power Solaris buses across Europe
Published: 2024-04-01 (Crawled : 12:30) - prnewswire.com
BLDP | $2.59 -1.52% -1.54% 3.4M twitter stocktwits trandingview |
Producer Manufacturing
| | O: 11.87% H: 6.27% C: 5.14%

europe company order
Xometry Europe Expands Finishing Options On Its AI-Driven Marketplace, Introduces The Xometry.Pro Knowledge Hub, And Launches A New Local-Language Czech Website
Published: 2024-03-21 (Crawled : 12:30) - globenewswire.com
XMTR | $17.37 7.55% 7.02% 630K twitter stocktwits trandingview |
Retail Trade
| | O: 1.15% H: 2.17% C: -3.48%

europe
NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event
Published: 2024-03-14 (Crawled : 12:30) - biospace.com/
NLSP | $0.1348 3.77% 3.64% 320K twitter stocktwits trandingview |
| | O: 2.52% H: 0.0% C: -4.31%


Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
CANF | $1.97 -0.51% 0.0% 3.8K twitter stocktwits trandingview |
Health Technology
| | O: -0.45% H: 2.27% C: 2.27%

europe liver conference distribution pancreatic treatment namodenoson
Venus Concept Announces CE Mark for Venus Versa Pro in Europe
Published: 2024-02-22 (Crawled : 12:30) - globenewswire.com
VERO | $0.787 -6.79% -7.28% 19K twitter stocktwits trandingview |
Health Technology
| | O: 37.7% H: 31.85% C: 10.71%

europe pro
Novocure Announces FDA Acceptance of the PMA Application for TTFields Therapy in Non-Small Cell Lung Cancer
Published: 2024-01-18 (Crawled : 12:30) - biospace.com/
NVCR | $12.055 1.9% 1.87% 750K twitter stocktwits trandingview |
Health Technology
| | O: 4.19% H: 21.15% C: 12.06%

fda lung cancer cell application therapy
Ballard announces orders for over 170 hydrogen fuel cell engines to power Solaris buses in Europe
Published: 2023-10-10 (Crawled : 12:30) - prnewswire.com
BLDP | $2.59 -1.52% -1.54% 3.4M twitter stocktwits trandingview |
Producer Manufacturing
| | O: 0.29% H: 6.86% C: 6.86%

europe cell hydrogen
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting
Published: 2023-09-21 (Crawled : 12:30) - biospace.com/
ENDPQ | News | $0.0007 -50.0% 1K twitter stocktwits trandingview |
n/a
| | O: 0.0% H: 0.0% C: 0.0%

meeting
Policlinico Gemelli and Palantir Technologies Partner to Use AI to Advance Data Science for Healthcare
Published: 2023-09-08 (Crawled : 12:30) - biospace.com/
PLTR | $21.64 3.2% 0.42% 36M twitter stocktwits trandingview |
Technology Services
| | O: -0.59% H: 3.24% C: 0.07%


ADC Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
Published: 2022-03-03 (Crawled : 12:30) - biospace.com/
ADCT | $4.97 6.2% 2.21% 400K twitter stocktwits trandingview |
Health Technology
| | O: 3.0% H: 0.0% C: -13.12%

financial results therapeutics report results
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce the Submission of a Marketing Authorization Application to the European Medicines Agency for PRX-102 for the Treatment of Fabry Disease
Published: 2022-02-24 (Crawled : 12:30) - prnewswire.com
PLX | $1.2 1.7% 0.0% 270K twitter stocktwits trandingview |
Health Services
| | O: -5.77% H: 3.69% C: 1.25%

prx-102 treatment europe application rare therapeutics disease authorization iot submission prx012
Immunic, Inc. to Present Preclinical Data for Vidofludimus Calcium at the 17th Congress of European Crohn's and Colitis Organization
Published: 2022-02-18 (Crawled : 12:30) - biospace.com/
IMUX | $1.25 1.63% 1.6% 200K twitter stocktwits trandingview |
Health Technology
| | O: -1.16% H: 0.47% C: -1.88%

europe preclinical pre-clinical vidofludimus calcium
Exela Expands Mastercard Relationship in Europe
Published: 2022-01-12 (Crawled : 12:30) - globenewswire.com
XELA | $1.975 -1.74% -1.77% 91K twitter stocktwits trandingview |
Technology Services
| | O: -1.34% H: 1.53% C: -5.86%

europe expansion
Exela Cements Europe Presence with Purchase of Headquarters in Ireland
Published: 2022-02-08 (Crawled : 12:30) - globenewswire.com
XELA | $1.975 -1.74% -1.77% 91K twitter stocktwits trandingview |
Technology Services
| | O: 1.33% H: 4.09% C: -4.53%

europe
Roivant Sciences Reports Financial Results for the Quarter Ended December 31, 2021 and Provides Business Update
Published: 2022-02-14 (Crawled : 12:30) - biospace.com/
ROIV | $10.935 3.16% 3.06% 5M twitter stocktwits trandingview |
Manufacturing
| | O: 2.63% H: 2.84% C: 2.42%

financial results ces report results
CureVac Doses First Participant in Phase 1 Study with Multivalent Influenza Vaccine Candidate Based on Second-Generation mRNA Backbone Developed in Collaboration with GSK
Published: 2022-02-10 (Crawled : 12:30) - biospace.com/
CVAC | $2.585 2.17% 2.13% 610K twitter stocktwits trandingview |
Health Technology
| | O: 2.16% H: 3.12% C: -4.13%

bone one phase 1 collaboration vaccine influenza
uniQure Announces Dosing of First Patients in European Open-Label Clinical Trial of AMT-130 Gene Therapy in Huntington’s Disease
Published: 2022-02-07 (Crawled : 12:30) - globenewswire.com
QURE | $4.755 -1.35% -1.37% 460K twitter stocktwits trandingview |
Health Technology
| | O: 5.55% H: 2.06% C: -0.06%

amt-130 huntington europe gene therapy trial label disease therapy huntington’s disease
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Surgery
Published: 2022-01-27 (Crawled : 12:30) - biospace.com/
MRK | $126.88 -0.05% -0.13% 7.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.91% H: 4.05% C: 2.75%

keytruda europe renal cel therapy cell carcinoma
MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Alcohol Use Disorder in Europe
Published: 2022-01-27 (Crawled : 12:30) - biospace.com/
MNOV | $1.34 -3.73% 9.3K twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: -6.0%

mn-166 alcohol use disorder treatment europe order patent grant
MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-001 and MN-002 for Hepatic Ballooning in Europe
Published: 2022-01-26 (Crawled : 12:30) - biospace.com/
MNOV | $1.34 -3.73% 9.3K twitter stocktwits trandingview |
Health Technology
| | O: 1.31% H: 6.03% C: 2.16%

mn-001 europe patent
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.